Paul Walfish

Q: What Schools Are Affiliated With Paul Walfish

Paul Walfish is affiliated with the following schools: University of Toronto, University of California, San Francisco

Paul Walfish's AcademicInfluence.com Rankings

Paul Walfish

Philosophy

#9868

World Rank

#13487

Historical Rank

Logic

#6970

World Rank

#8550

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Paul Walfish Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Paul Gerald Walfish, was a Canadian endocrinologist "whose research in the area of thyroid physiology and pathology has contributed to improved health care in Canada, especially for newborn infants".

(See a Problem?)

Paul Walfish's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. (1997) (440)
Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. (2003) (436)
Screening for congenital hypothyroidism: results of screening one million North American infants. (1979) (378)
Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. (1997) (258)
Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients (2004) (241)
Plasma free fatty acid concentrations in obesity. (1963) (216)
Non-diagnostic fine needle aspiration biopsy: a dilemma in management of nodular thyroid disease. (1993) (173)
Prospective management of nodal metastases in differentiated thyroid cancer. (1991) (169)
Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. (1995) (167)
Combined ultrasound and needle aspiration cytology in the assessment and management of hypofunctioning thyroid nodule. (1977) (152)
Ultrasound-guided fine-needle aspiration biopsy in the management of thyroid disease. (1993) (151)
CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. (1998) (144)
POST-PARTUM TRANSIENT THYROTOXICOSIS WITH PAINLESS THYROIDITIS (1977) (131)
Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. (2002) (131)
Increased risk of primary hypothyroidism in preterm infants. (1984) (131)
Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants (2016) (120)
EVALUATION OF THREE THYROID-FUNCTION SCREENING TESTS FOR DETECTING NEONATAL HYPOTHYROIDISM (1976) (116)
Induction of painless thyroiditis in patients receiving programmed death 1 receptor immunotherapy for metastatic malignancies. (2015) (115)
Mechanisms of action of the congenital diaphragmatic hernia-inducing teratogen nitrofen. (2007) (111)
Management and outcome of recurrent well-differentiated thyroid carcinoma. (2004) (101)
Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil. (1979) (98)
Clinical Course of Thyroid Carcinoma After Neck Dissection (2003) (97)
Antithyroid microsomal autoantibodies and HLA-DR5 are associated with postpartum thyroid dysfunction: evidence supporting an autoimmune pathogenesis. (1988) (92)
B-mode ultrasonography in assessment of thyroid gland lesions. (1973) (84)
Prevalence and characteristics of post-partum thyroid dysfunction: results of a survey from Toronto, Canada (1992) (84)
Pathologic nature of cystic thyroid nodules selected for surgery by needle aspiration biopsy. (1986) (83)
Susceptibility to thyroid autoimmune disease: molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. (1990) (82)
Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways. (2002) (82)
The thyrotoxicosis of hydatidiform mole. (1975) (77)
EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis (2010) (77)
INAPPROPRIATE TRIIODOTHYRONINE (T3) AND THYROXINE (T4) RADIOIMMUNOASSAY LEVELS SECONDARY TO CIRCULATING THYROID HORMONE AUTOANTIBODIES (1978) (74)
Application of post‐surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low‐risk papillary thyroid carcinoma (2010) (72)
Pregnancy as a predisposing factor in thyroid neoplasia. (1986) (71)
Thyroid Hormone Response Element Organization Dictates the Composition of Active Receptor* (2007) (71)
Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry. (1986) (69)
Concurrent aortic and mitral valve echocardiography permits measurement of systolic time intervals as an index of peripheral tissue thyroid functional status. (1989) (68)
Serum triiodothyronine and other clinical and laboratory indices of alcoholic liver disease. (1979) (67)
Clinical Significance of Altered Expression of β-Catenin and E-Cadherin in Oral Dysplasia and Cancer: Potential Link with ALCAM Expression (2013) (66)
Congenital thyroid hemiagenesis. (1995) (65)
Reevaluation of needle aspiration cytology in detection of thyroid cancer. (1981) (65)
Yeast hormone response element assays detect and characterize GRIP1 coactivator-dependent activation of transcription by thyroid and retinoid nuclear receptors. (1997) (63)
Prognostic Variables and Calcitonin in Medullary Thyroid Cancer (2005) (63)
Sellar enlargement with hyperprolactinemia and a Rathke's pouch cyst. (1978) (62)
Recommendations for screening programs for congenital hypothyroidism (1976) (59)
Thyroid nodular disease in pregnancy: current diagnosis and management. (1997) (58)
A prospective study of combined ultrasonography and needle aspiration biopsy in the assessment of the hypofunctioning thyroid nodule. (1977) (58)
Extrathyroidal extension in well-differentiated thyroid cancer: macroscopic vs microscopic as a predictor of outcome. (2007) (57)
Influence of fine-needle aspiration biopsy and frozen section examination on the management of thyroid cancer. (1993) (57)
Management considerations in Hürthle cell carcinoma. (1995) (56)
Interferon-γ Gene Microsatellite Polymorphisms in Patients with Graves' Disease (1998) (56)
Effects of estradiol benzoate on thyroid-pituitary function in female rats. (1978) (55)
Postparathyroidectomy transient thyrotoxicosis. (1992) (51)
6 Post-partum hyperthyroidism (1985) (51)
GCN5 and ADA adaptor proteins regulate triiodothyronine/GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor. (2000) (50)
Pregnancy and surgical thyroid disease. (1985) (49)
Results of a regional cord blood screening programme for detecting neonatal hypothyroidism. (1979) (48)
Autoimmune thyroiditis associated with mild "subclinical" hypothyroidism in adults with Down syndrome: a comparison of patients with and without manifestations of Alzheimer disease. (1990) (48)
Malignant pseudothyroiditis: a new clinical entity. (1978) (46)
Polymorphisms of TAP1 and TAP2 genes in Graves' disease. (1997) (46)
Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers (2010) (46)
S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia (2014) (45)
Congenital hypothyroidism (1981) (45)
Arsenical-based affinity chromatography of vicinal dithiol-containing proteins: purification of L1210 leukemia cytoplasmic proteins and the recombinant rat c-erb A beta 1 T3 receptor. (1993) (43)
Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma (2003) (42)
Association of premature ovarian failure with HLA antigens. (2008) (42)
Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer (2015) (41)
Transglutaminase 2 Overexpression in Tumor Stroma Identifies Invasive Ductal Carcinomas of Breast at High Risk of Recurrence (2013) (40)
Effects of age and ovarian function on the pituitary-thyroid system in female rats. (1978) (39)
Effects of age and testicular function on the pituitary-thyroid system in male rats. (1979) (39)
Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast. (1996) (37)
Intraoperative parathormone level measurement in the management of hyperparathyroidism. (1990) (37)
Secretome-based identification and characterization of potential biomarkers in thyroid cancer. (2010) (37)
Parathyroid cysts. Medical diagnosis and management. (1978) (36)
Lithiumogenic disorders of the thyroid and parathyroid glands as surgical disease. (1990) (36)
Cause of Death in Patients With Well‐Differentiated Thyroid Carcinoma (2001) (34)
Preferential release of triiodothyronine: an intrathyroidal adaptation to reduced serum thyroxine in aging rats. (1983) (34)
Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer (2015) (34)
Thyroid cancer outcomes in Filipino patients. (2010) (34)
Recommendations for screening programs for congenital hypothyroidism. Report of a committee of the American Thyroid Association. (1976) (33)
Slug Is a Predictor of Poor Prognosis in Esophageal Squamous Cell Carcinoma Patients (2013) (33)
Neonatal Thyroid Function in Iodine Deficiency (1993) (32)
The Adenovirus E1A Protein Targets the SAGA but Not the ADA Transcriptional Regulatory Complex through Multiple Independent Domains* (2002) (32)
Application of special diagnostic techniques in the management of nodular goitre. (1976) (31)
Oral calcium load test: diagnostic and physiologic implications in hyperparathyroidism. (1990) (31)
Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis (2014) (31)
Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (2017) (30)
Pituitary prolactin cell hyperplasia. (1980) (30)
Hypogonadotropic hypogonadism in idiopathic hemochromatosis: evidence for combined hypothalamic and pituitary involvement (1990) (29)
Kinetic characteristics of a thioredoxin-activated rat hepatic and renal low-Km iodothyronine 5'-deiodinase. (1989) (29)
Hypothalamic secretion of thyrotropin releasing hormone declines in aging rats. (1987) (28)
Relevance of vitamin D metabolite concentrations in supporting the diagnosis of primary hyperparathyroidism. (1991) (26)
Polyglandular autoimmune syndrome: current concepts. (1988) (26)
Transient neonatal hypothyroidism is associated with elevated serum anti-thyroglobulin antibody levels in newborns and their mothers. (2007) (26)
Interferon-gamma gene microsatellite polymorphisms in patients with Graves' disease. (1998) (26)
An analysis of the variation of incidence of congenital dysgenetic hypothyroidism in various countries. (1984) (25)
Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer (2015) (25)
E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode. (2005) (25)
Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well‐differentiated thyroid carcinoma (2008) (24)
Cellular context of coregulator and adaptor proteins regulates human adenovirus 5 early region 1A-dependent gene activation by the thyroid hormone receptor. (2003) (24)
Management implications from routine needle biopsy of hyperfunctioning thyroid nodules. (1985) (24)
Papillary thyroid carcinoma metastasizing to the sphenoid-ethmoid sinuses and skull base. (1996) (24)
Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas (2013) (23)
Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients (2015) (23)
Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy (2015) (23)
The application of ultrasound to the study of thyroid enlargement: management of 450 cases. (1975) (23)
The use of B mode ultrasonography in changing indications for thyroid operations. (1974) (23)
Ultrasonography of the thyroid gland. (1975) (23)
Requirement of co-factors for the ligand-mediated activity of the insect ecdysteroid receptor in yeast. (2001) (22)
The ultrasound of thyroid masses. (1979) (22)
Rat liver c-erb A beta 1 thyroid hormone receptor is a constitutive activator in yeast (Saccharomyces cerevisiae): essential role of domains D,E and F in hormone-independent transcription. (1991) (21)
Sulfonylurea-induced factitious hypoglycemia in a nondiabetic nurse. (1975) (20)
Properties of cytosolic components activating rat hepatic 5-deiodination in the presence of NADPH (1986) (20)
Binding of reverse triiodothyronine to serum immunoglobulins in man and the rabbit. (1980) (20)
Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma (2012) (19)
Thionamides and arsenite inhibit specific T3 binding to the hepatic nuclear receptor. (1990) (18)
Increase in antimicrosomal antibody-related lgG1 and lgG4, and titers of antithyroid peroxidase antibodies, but not antibody dependent cell-mediated cytotoxicity in post-partum thyroiditis with transient hyperthyroidism (1990) (18)
THE IMMUNOGENETIC BASIS OF AUTOIMMUNE THYROID DISEASE (1985) (18)
Effects and clinical significance of exogenous thyroxine therapy in patients with circulating thyroid hormone autoantibodies. (1982) (17)
An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma (2012) (17)
Beta Adrenergic Receptor Mechanisms in the Metabolic Effects of Diazoxide in Fasted Rats (1970) (17)
Thyrotropin-releasing hormone levels decrease in hypothalamus of aging rats (1984) (16)
The subhyoid ectopic median thyroid. (1967) (16)
Adverse aspects of small thyroid cancer and need for treatment (1995) (16)
Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness (2012) (15)
THYROTROPHIN BLOCKING ANTIBODIES IN THE SERA OF MOTHERS WITH CONGENITALLY HYPOTHYROID INFANTS (1986) (15)
Parathyroid cancer: clinical variations and relationship to autotransplantation. (1994) (14)
Individualized five-year risk assessment for oral premalignant lesion progression to cancer. (2017) (14)
Efficacy of needle biopsy in postradiation thyroid disease. (1983) (14)
A diurnal pattern in the rate of disappearance of I-131-labeled 1-thyroxine from the serum. (1961) (13)
Graves' hyperthyroidism after postpartum thyroiditis. (1998) (13)
3,3',5'-triiodothyronine, thyroxine, triiodothyronine, and thyrotropin levels in maternal and cord blood sera from endemic goiter regions of Brazil. (1978) (12)
Triiodothyronine and thyroxine interrelationships in health and disease. (1976) (12)
Congenital hypothyroidism. The effect of stopping treatment at 3 years of age. (1985) (11)
Factitious hyperinsulinemic hypoglycemia: confirmation of the diagnosis by a species-specific insulin radioimmunoassay (1987) (11)
Post-partum hyperthyroidism. (1985) (11)
Serial post-surgical stimulated and unstimulated highly sensitive thyroglobulin measurements in low- and intermediate-risk papillary thyroid carcinoma patients not receiving radioactive iodine (2016) (11)
Bacterial and mammalian thioredoxin systems activate iodothyronine 5'-deiodination. (1988) (11)
Iodine nutrition during pregnancy in Toronto, Canada. (2013) (11)
5'-Iodothyronine deiodinase of rat liver: activity in microsomes prepared by various methods, solubilization by detergents and partial purification. (1985) (10)
Intrathyroidal activated (Ia+) T-lymphocyte CD+ subsets and B cells in Graves' hyperthyroidism respond rapidly to propylthiouracil therapy: demonstration using fine needle aspirates and two-colour laser flow cytometry. (1992) (10)
In vivo expression of rat liver c-erbA beta thyroid hormone receptor in yeast (Saccharomyces cerevisiae). (1990) (10)
Identification of CCR4 and other essential thyroid hormone receptor co-activators by modified yeast synthetic genetic array analysis (2009) (10)
Cost savings of patients with a MACIS score lower than 6 when radioactive iodine is not given. (2007) (10)
Graves' disease in a woman with thyroid hormone abuse, bulimia nervosa, and a history of anorexia nervosa (1991) (10)
Prognostic implications of site of recurrence in patients with recurrent well-differentiated thyroid cancer. (2004) (9)
Activated leukocyte cell adhesion molecule is a marker for thyroid carcinoma aggressiveness and disease-free survival. (2013) (9)
Esophageal carcinoma masquerading as recurrent acute suppurative thyroiditis. (1985) (9)
Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients (2014) (9)
The adenoviral E1A protein displaces corepressors and relieves gene repression by unliganded thyroid hormone receptors in vivo (2009) (9)
Results of the Toronto Regionalized Screening Program for Detecting Neonatal Hypothyroidism (1980) (8)
T3/T4 RATIO IN THYROID DISEASE (1978) (8)
Cross-talk between thyroid hormone and specific retinoid X receptor subtypes in yeast selectively regulates cognate ligand actions. (1996) (8)
Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine-Needle Aspiration Biopsy Clinical Application. (2015) (8)
The assessment of thyroid function and structure. (1978) (8)
Quantitative plasma binding capacity studies of thyroxine-binding globulin by use of a modification of the erythrocyte 1-triiodothyronine-1-131 uptake test. (1962) (7)
NADPH-dependent generation of a cytosolic dithiol which activates hepatic iodothyronine 5'-deiodinase. Demonstration by alkylation with iodoacetamide. (1986) (7)
Graves' ophthalmopathy and subclinical hypothyroidism: diagnostic value of the thyrotropin releasing hormone test. (1982) (7)
Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis (2016) (7)
Screening for neonatal hypothyroidism: comparison of neonatal dried capillary blood thyroxine (T4) to cord serum T4 and thyrotropin (TSH) (1976) (7)
Cytosolic cofactors and dihydrolipoamide stimulate hepatic microsomal 5'-deiodination. (1985) (7)
Clinical endocrinology : a survey of current practice (1977) (6)
Problems in screening for congenital hypothyroidism using thyroxine assays from small dried blood discs. (1981) (6)
The use of toluidine blue in locating abnormal parathyroid tissue at operation. (1974) (6)
Experience with the Application of a Dried Blood Thyrotropin (TSH) Method for Neonatal Hypothyroidism Screening: Comparative Studies Between Double-Antibody and Solid Phase Radioimmunoassays (1980) (6)
Cord serum thyroxine and thyrotropin values between 20 and 30 weeks' gestation. (1979) (6)
Adrenal insufficiency after recurrent post-partum thyroiditis (post-partum Schmidt syndrome): a case report. (1998) (6)
ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy (2016) (6)
A rapid double antibody non-equilibrium serum thyrotropin radioimmunnoassay suitable for primary neonatal hypothyroidism screening. (1979) (5)
Human nuclear receptor heterodimers: opportunities for detecting targets of transcriptional regulation using yeast. (1996) (5)
Programmed death-ligand 1 expression by digital image analysis advances thyroid cancer diagnosis among encapsulated follicular lesions (2018) (5)
Selective effect of zinc compared to other divalent metals on L-triiodothyronine binding to rat c-erbA alpha and beta proteins. (1990) (5)
Cut-off for supplementary TSH testing in a T4 screening program for congenital hypothyroidism. (1981) (5)
Polyglandular autoimmune syndrome type II. (1988) (5)
Activated leukocyte cell adhesion molecule (ALCAM/CD166) is a marker for thyroid cancer aggressiveness and disease-free survival. (2012) (4)
Rat hepatic and renal 5'-deiodination of rT3 during fasting: supportive role of intermediate Mr cytosolic non-glutathione thiol cofactor and NADPH. (1989) (4)
Corepressor/coactivator paradox: potential constitutive coactivation by corepressor splice variants (2006) (4)
Thioredoxin and glutaredoxin enhance the binding of L-triiodothyronine to its hepatic nuclear receptors. (1989) (4)
Testing your older patient's thyroid function. (1982) (4)
INSULIN 1‐131 DISAPPEARANCE RATES FOLLOWING DIAZOXIDE, EPINEPHRINE AND GLUCOSE ADMINISTRATION (1968) (4)
Intermediate Mr cytosolic components potentiate hepatic 5'-deiodinase activation by thiols. (1986) (4)
Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model (2014) (4)
Methodologic Limitations on the Measurement of Thyroxine from Small Dried Blood Discs: Comparison of Double-Antibody and Solid Phase Radioimmunoassays (1980) (4)
Stimulated thyroglobulin and neck ultrasonography facilitates postsurgical radioactive iodine remnant ablation selection in patients with low-risk well-differentiated thyroid carcinoma. (2012) (4)
Postpartum thyroid disease. (1978) (4)
Metastasis of cancer of the thyroid gland as a cause of goitre. (1978) (3)
RETRACTED: Straticyte demonstrates prognostic value over oral epithelial dysplasia grade for oral potentially malignant lesion assessment. (2017) (3)
Improved α-glycerophosphate dehydrogenase assay system suitable for continuous recording (1982) (3)
Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy (2015) (3)
The adenovirus 55 residue E1A protein is a transcriptional activator and binds the unliganded thyroid hormone receptor. (2014) (3)
Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in “Low Risk” Prostate Adenocarcinomas (2015) (3)
Properties of cytosolic components activating rat hepatic 5' [corrected]-deiodination in the presence of NADPH. (1986) (3)
Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis. (1986) (3)
Editor's column: Recommendations for screening programs for congenital hypothyroidism. Report of a Committee of The American Thyroid Association. (1976) (3)
Thyroid Function and Male Reproduction (1980) (3)
Sequelae of radiation facial epilation (North American Hiroshima maiden syndrome). (1989) (3)
Yeast hormone response element assays detect and characterize GRIP 1 coactivator-dependent activation of transcription by thyroid and retinoid nuclear receptors ( cell biology y thyroid hormone y transcriptional regulation y subtype specificity y nuclear receptor-interacting protein ) (1997) (2)
Experience with an in vitro test of thyroid function--the red blood cell uptake of L-triiodothyronine labelled with radioactive iodine. (1961) (2)
A new unextracted-sample radioimmunoassay method for hepatic endogenous nuclear L-tri-iodothyronine content. Validity of its use in determining nuclear receptor binding characteristics. (1982) (2)
HLA antigens in painless thyroiditis with transient hyperthyroidism. (1982) (2)
Increased Frequency of HLA-DR5 in Metro Toronto Patients with Goitrous Autoimmune Thyroiditis and Post-Partum Thyroiditis (1987) (2)
Cord blood screening for congenital hypothyroidism (1978) (2)
Activation of detergent-solubilized rat hepatic 5'-iodothyronine deiodinase by NADPH and nonglutathione cytosolic components. (1988) (1)
Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis (2014) (1)
THE THYROTOXICOSIS OF HYDATIDIFORM MOLE (1976) (1)
Clinical application of triiodothyronine measurement. (1977) (1)
Strongest Relative Risk for Goitrous Hashimoto’s Thyroiditis Conferred by HLA-DQB1 Gene Variation (1991) (1)
Letter to the Editor referring to the retracted publication entitled "Straticyte demonstrates prognostic value over oral epithelial dysplasia grade for oral potentially malignant lesion assessment" by Hwang et al. (2018) (1)
Detection of incipient primary hypothyroidism (IPH) using serum triiodothyronine (T3) and thyrotropin (TSH) responses to thyrotropin releasing hormone (TRH) (1975) (1)
Mitochondrion-desmosome complexes in the pituitary follicles of the rat. (1979) (1)
Reply: (2011) (1)
Yeast hormone response element assays detect and characterize GRIPI coactivator dependent activation of thyroid and retinoid nuclear receptors (1997) (1)
IODINE NUTRITION DURING PREGNANCY IN TORONTO, CANADA Running title: Canadian iodine status in pregnancy (2012) (0)
Dedifferentiation and rapid growth of a giant thyroid mass. (1998) (0)
Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients (2014) (0)
Cytosol components from human placenta and rat liver in iodothyronine 5- and 5'-deiodination. (1989) (0)
Personalized Risk Criteria for Radioactive Iodine Therapy in Thyroid Cancer (2017) (0)
P124 Cost Savings of Patients With a MACIS Score Lower Than 6 When Radioactive Iodine Treatment Is Not Given (2006) (0)
Subclinical hyperthyroidism. (2000) (0)
Thyroid pathophysiology: reflections on physician-scientist careers in thyroidology. (2010) (0)
Use of Personalized Post-Total Thyroidectomy Criteria in Low and Intermediate Risk Papillary Thyroid Cancer Patients to avoid Routine Radioactive Iodine Administration (2017) (0)
P164 Extrathyroidal Extension in Well-Differentiated Thyroid Cancer as a Predictor of Outcome Measures (2006) (0)
Transglutaminase II expression in invasive ductal carcinomas. (2013) (0)
Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer (2015) (0)
Dr. Robert Volpé, OC, M.D., FRCP(C), MACP (2005) (0)
Abstract P2-10-07: Ep-ICD overexpression associates with poor prognosis in invasive ductal carcinoma (2013) (0)
Radioiodine ablation in low-risk thyroid cancer. (2012) (0)
Generated Dihydrolipoamide and Cytosolic Components Stimulate Hepatic Microsomal Thyroxine 5’-Deiodination: Similar Effects of Cytosolic Components on Other Sulfhydryl Compounds (1986) (0)
Age-related changes in rat hepatic and renal thyroid hormone-sensitive enzymes — different responses to acute and chronic l-triiodothyronine stimulation (1988) (0)
Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients (2015) (0)
Colic and urinary tract infection. (1977) (0)
NADPH with Cytosol Stimulates Deiodination by Detergent-Solubilized Hepatic Microsomes: Evidence for NADPH-Dependent Cytosolic Non-Glutathione Reductase System (1986) (0)
RETRACTED: Straticyte demonstrates prognostic value over oral epithelial dysplasia grade for oral potentially malignant lesion assessment. (2018) (0)
Margita Zakarija, M.D., M.Sc. 1937–2006 (2007) (0)
Thioredoxin and glutaredoxin systems of rat liver cytosol are not influenced by thyroid dysfunction. (1989) (0)
STRATICYTE, A COMPLEMENT TO HISTOPATHOLOGY FOR CANCER PROGRESSION RISK ASSESSMENT OF ORAL EPITHELIAL DYSPLASIA (2017) (0)
Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis (2016) (0)
A Novel Prognostic Assessment for Identifying Oral Pre-Malignant Lesions at High Risk for Progression to Cancer (2016) (0)
Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma (2012) (0)
Problems in Screening for CongenitalHypothyroidismUsingThyroxine Assays from Small Dried BloodDiscs (2006) (0)
Survey of Post-Partum Thyroid Antimicrosomal Autoantibody as a Marker for Thyroid Dysfunction (1987) (0)
Congenital hypothyroidism. Clinical andlaboratory characteristics ininfants detected byneonatal screening (1981) (0)
Peripheral Metabolism and Action of Thyroid Hormones (1977) (0)
Thyroid colloid nodules diagnosed by fine-needle aspiration: efficacy of suppression. (2004) (0)
Autoimmunity and the thyroid (1985) (0)
Improved alpha-glycerophosphate dehydrogenase assay system suitable for continuous recording. (1982) (0)
Invited commentary (2006) (0)

This paper list is powered by the following services:

Other Resources About Paul Walfish

en.wikipedia.org

What Schools Are Affiliated With Paul Walfish?

Paul Walfish is affiliated with the following schools: